New England Private Wealth Advisors LLC Sarepta Therapeutics, Inc. Transaction History

New England Private Wealth Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$72.81 - $156.91 $181,588 - $391,333	-2,494 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$112.21 - $151.95 $56,778 - $76,886	506 Added 25.45%	2,494 $379,000
Q1 2019 May 02, 2019	BUY	$106.67 - $151.68 $212,059 - $301,539	1,988 New	1,988 $237,000
Q4 2018 Feb 12, 2019	SELL	$97.32 - $148.76 $137,805 - $210,644	-1,416 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$115.31 - $161.51 $163,278 - $228,698	1,416 New	1,416 $229,000

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of New England Private Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on New England Private Wealth Advisors LLC with notifications on news.